Michael Heise

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma

Edward K. Geissler, Andreas A. Schnitzbauer, C. Zülke et al. · Transplantation · 2015 · 417 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma

Gerd Otto, Sascha Herber, Michael Heise et al. · Liver Transplantation · 2006 · 412 citations · Full text

Medicine, Oncology, Surgery +16

Venous complications after orthotopic liver transplantation

Utz Settmacher, Nc Nüssler, Matthias Glanemann et al. · Clinical Transplantation · 2000 · 186 citations

Medicine, Surgery, Hepatology +14

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

Andreas A. Schnitzbauer, Carl Zuelke, Christian Graeb et al. · BMC Cancer · 2010 · 160 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Radiofrequency Ablation as First-Line Treatment in Patients With Early Colorectal Liver Metastases Amenable to Surgery

Gerd Otto, Christoph Düber, Maria Hoppe‐Lotichius et al. · Annals of Surgery · 2010 · 157 citations

Medicine, Oncology, Surgery +17